People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

24.56USD
21 Nov 2014
Price Change (% chg)

$0.30 (+1.24%)
Prev Close
$24.26
Open
$24.60
Day's High
$24.67
Day's Low
$24.08
Volume
139,926
Avg. Vol
208,875
52-wk High
$28.48
52-wk Low
$19.31

Search Stocks

Richard, Ronald 

Brief Biography

Mr. Ronald B. Richard is Lead Independent Director of Emergent BioSolutions Inc. Mr. Richard has served as the president and chief executive officer of the Cleveland Foundation, the nation’s oldest community foundation, since June 2003. From August 2002 to February 2003, Mr. Richard served as president of Stem Cell Preservation, Inc., a start-up medical research company. After leaving Stem Cell Preservation and prior to joining Emergent BioSolutions, Mr. Richard served as a strategic business advisor for IGEN International, Inc., a biotechnology company. Mr. Richard served as chief operating officer of In-Q-Tel, a venture capital fund that provides technologies to the Central Intelligence Agency, from March 2001 to August 2002. Prior to joining In-Q-Tel, Mr. Richard served in various senior management positions at Matsushita Electric (Panasonic), a consumer electronics company. Mr. Richard is a former U.S. foreign service officer. He served in Osaka/Kobe, Japan and as a desk officer for North Korean, Greek and Turkish affairs at the U.S. Department of State in Washington, D.C. Mr. Richard previously served as chairman of the board of trustees of the International Biomedical Research Alliance, an academic joint venture among the NIH, Oxford University and Cambridge University. Mr. Richard received an M.A. in international relations from Johns Hopkins University School of Advanced International Studies and a B.A. in history from Washington University. He holds an honorary doctorate in humane letters from Notre Dame College.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

1,295,470

Daniel Abdun-Nabi

2,160,850

Robert Kramer

800,747

Anatolio Cruz

--

Adam Havey

805,364

Barry Labinger

138,944
As Of 30 Dec 2013
Search Stocks